Clinical Trials Logo

Filter by:
NCT ID: NCT01010464 Withdrawn - Open Abdomen Clinical Trials

An Adhesion Reduction Plan in the Management of the Surgical Open Abdomen

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether an adhesion reduction plan, consisting of early adhesion prevention and application of a bioresorbable membrane is effective in reducing the severity of adhesions and the incidence of complications in managing the open abdomen in trauma and emergency general surgery.

NCT ID: NCT01009944 Withdrawn - Hypertension Clinical Trials

Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study

Start date: January 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to develop an approach to provide personalized medicine to individuals who have hypertension (high blood pressure). The investigators plan to use people's genetic characteristics (traits) to determine what medication they should use to lower their blood pressure most effectively. The investigators will give individuals one of two medications to treat hypertension (lisinopril or atenolol). The investigators believe that depending on the individuals genetic background one medication will work better in lowering their blood pressure.

NCT ID: NCT01009879 Withdrawn - Clinical trials for Rheumatoid Arthritis

Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants

Start date: November 2009
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the effects of TNF (tumor necrosis factor; a mediator of inflammation) on B cells in patients with rheumatoid arthritis. TNF and B cells are important in rheumatoid arthritis because they both appear to be involved in causing rheumatoid arthritis.

NCT ID: NCT01008397 Withdrawn - Clinical trials for Rhinitis, Allergic, Seasonal

Study of AHIST in Seasonal Allergic Rhinitis Patients

Start date: April 2011
Phase: Phase 1
Study type: Interventional

Objectives: A) To gather pharmacodynamic measurements and assess blood levels of the active ingredients in AHIST over the dosage interval period of 12 hours. Hypothesis: Hysteresis curves plotting each active ingredient's blood levels over a 12-hour dosage interval will substantiate S5 Symptom Diary scores (IE: evidentiary therapeutic window data); B) To report subjective scores by subjects rating the efficacy of a single dose AHIST in relieving nasal congestion, rhinorrhea, nasal itching, sneezing, and post-nasal drip over a 12-hour dosage interval. Hypothesis: Greater than 66% of subjects will document clinically significant relief over a 12-hour period from one dose of AHIST; C) Report any side effects or adverse drug reactions and rate the severity of any incidence. Hypothesis: Not more than one patient will have an adverse event significant enough to warrant withdrawal; side effects will be mild with the most frequently reported side effect occurring in less than 10% of patients—drowsiness.

NCT ID: NCT01008371 Withdrawn - Obesity Clinical Trials

Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.

Start date: October 2009
Phase: N/A
Study type: Observational

The purpose of this study is to determine abnormal neuro-hormonal mechanisms that may impair the ability to feel full and which therefore, may lead to obesity.

NCT ID: NCT01008124 Withdrawn - Vertigo Clinical Trials

The Liberatory Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo (BPPV)

LM_BPPV
Start date: November 2009
Phase: N/A
Study type: Interventional

This study is being done because the investigators would like to know how effective the Liberatory maneuver is in treating benign paroxysmal positional vertigo (BPPV).

NCT ID: NCT01008111 Withdrawn - Wound Healing Clinical Trials

Wound Healing of Incisional Wounds for Bilateral Hernia Repair

Start date: October 2009
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to test the safety of an oxygen producing gel (produced by combining baking soda and hydrogen peroxide) and see what effects (good and bad) it has on skin incisions in children. Baking soda and hydrogen peroxide have been approved by the US Food and Drug Administration (FDA), but have not been approved for use in this manner. It is hypothesized that a combination of sodium bicarbonate and hydrogen peroxide may enhance wound healing of incisional wounds for bilateral hernia repair.

NCT ID: NCT01007773 Withdrawn - Clinical trials for Traumatic Brain Injury

Safety of Dexmedetomidine in Severe Traumatic Brain Injury

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The aim of this study is to assess the safety and feasibility of dexmedetomidine as an adjunct to conventional sedative therapy compared to conventional sedative therapy alone in patients with severe traumatic brain injury.

NCT ID: NCT01007084 Withdrawn - Trauma Clinical Trials

TRAUMA HELP: Healing and Analgesia With Propranolol

TRAUMA_HELP
Start date: October 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether propranolol can decrease pain symptoms in a common subset of patients admitted to a trauma center after injury.

NCT ID: NCT01007006 Withdrawn - Pain Clinical Trials

Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment

Start date: December 2010
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate whether use of TRMDU in addition to medication review leads to improved outcomes and reduced health care costs for patients when compared with medication review alone. The study will be conducted in patients assigned to Department of Defense (DOD) Warrior Transition Units (WTU's), similar DOD units, and VA polytrauma centers.